BioScrip Appoints John McMahon as Chief Accounting Officer
22 Octobre 2018 - 10:30PM
BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the
largest independent national provider of infusion and home care
management solutions, today announced the appointment of John
McMahon as Vice President, Controller and Chief Accounting Officer
of the Company, effective October 19, 2018.
Mr. McMahon is a certified public accountant and
has more than 25 years of accounting and finance experience,
including over a decade in principal accounting officer roles at
publicly traded companies, such as Heska Corporation where he was
the chief financial officer and Advanced Energy Industries, Inc.
where he was the corporate controller. Earlier in his career,
Mr. McMahon held senior accounting and audit positions with a
variety of other publicly traded companies, including Danka
Business Systems PLC, Sykes Enterprises, Inc. and
Documentum.
“John brings substantial public company
accounting and internal controls leadership to BioScrip. I am
very excited to welcome John, as his appointment is indicative of
the solid momentum our team has made toward building a
best-in-class accounting and finance organization. I look
forward to working closely with John and the rest of our team as we
continue to drive excellence with the support of our accounting and
finance functions,” said Stephen Deitsch, Senior Vice President and
Chief Financial Officer.
About BioScrip, Inc.
BioScrip, Inc. is the largest independent
national provider of infusion and home care management solutions,
with approximately 2,100 teammates and nearly 70 service locations
across the U.S. BioScrip partners with physicians, hospital
systems, payors, pharmaceutical manufacturers and skilled nursing
facilities to provide patients access to post-acute care services.
BioScrip operates with a commitment to bring customer-focused
pharmacy and related healthcare infusion therapy services into the
home or alternate-site setting. By collaborating with the full
spectrum of healthcare professionals and the patient, BioScrip
provides cost-effective care that is driven by clinical excellence,
customer service, and values that promote positive outcomes and an
enhanced quality of life for those it serves.
Investor Contacts:
Stephen Deitsch
Chief
Financial Officer & Treasurer
T: (720)
697-5200
stephen.deitsch@bioscrip.com
Kalle Ahl, CFAThe Equity GroupT: (212)
836-9614kahl@equityny.com
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024